Datasheet
Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics
This FAQ provides key information on vaccines and therapeutics for Bundibugyo virus disease (BVD), including current evidence, ongoing research, WHO recommendations, and key messages for national authorities and communities.
This document will be updated as new information becomes available.
Languages
Publication year
2026
Type
Datasheet
Categories
- Programme management
Diseases
- Ebola
Countries
- Democratic Republic Of The Congo
Organisations
- World Health Organization (WHO)
ebola-BDBV
You can find more information about "ebola-BDBV" in the following Hot Topics:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics | World Health Organization (WHO), WHO Regional Office for Africa (AFRO) | 2026 | Datasheet | English, French |
| WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026 | World Health Organization (WHO) | 2026 | Guidance | English |
| WHO Technical Advisory Group on Candidate Vaccine Prioritization Meeting report, 19 and 25 May 2026 | World Health Organization (WHO) | 2026 | Report | English |
| GNN webinar: Updates on existing and pipeline Ebola vaccines | Helen Rees, Reena Doshi, Alejandro Costa, Melanie Marti, Pierre Gsell | 2026 | Webinar | English |
